Physician profile
Ross E Nunes
NPI 1366588824
$1,832.04
in general payments reported to CMS, 2019-2025
17 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $410 · 2021: $486 · 2022: $208 · 2024: $81.11 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $454.32 | 2019-2025 | Invega Sustenna |
| Vanda Pharmaceuticals INC. | $294.86 | 2019-2025 | Fanapt |
| Abbvie INC. | $202.41 | 2021-2024 | |
| Allergan, INC. | $151.74 | 2019-2020 | |
| Indivior INC. | $144.52 | 2019-2024 | Perseris |
| Otsuka America Pharmaceutical, INC. | $112.58 | 2019-2020 | |
| Alkermes, INC. | $93.49 | 2019-2021 | |
| Lundbeck LLC | $88.09 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $65.49 | 2020-2025 | Austedo Xr, Uzedy |
| Sunovion Pharmaceuticals INC. | $47.02 | 2019-2021 | |
| Neuronetics, INC. | $42.58 | 2025 | Neurostar Tms Therapy System |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.67 | 2021-2022 | |
| Uswm, LLC | $28.44 | 2024 | Lucemyra |
| E.R. Squibb & Sons, L.L.C. | $21.61 | 2025 | Cobenfy |
| Neurocrine Biosciences, INC. | $18.75 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $13.36 | 2019 | |
| Supernus Pharmaceuticals, INC. | $12.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Nunes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.